bioRxiv preprint doi: https://doi.org/10.1101/314716; this version posted May 8, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Analysis of the human kinome and phosphatome reveals diseased signaling networks induced by overexpression Xiao-Kang Lun1,2, Damian Szklarczyk1*, Attila Gábor3*, Nadine Dobberstein1, Vito RT Zanotelli1,4, Julio Saez-Rodriguez3, 5#, Christian von Mering1#, and Bernd Bodenmiller1 1 Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland 2 Molecular Life Science Ph.D. Program, Life Science Zürich Graduate School, ETH Zürich and University of Zürich, Zürich, Switzerland 3 Joint Research Centre for Computational Biomedicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany 4 Systems Biology Ph.D. Program, Life Science Zürich Graduate School, ETH Zürich and University of Zürich, Zürich, Switzerland 5European Bioinformatics Institute, European Molecular Biology Laboratory (EMBL-EBI) Hinxton, Cambridge, UK *These authors contributed equally to the manuscript. # These authors contributed equally to the manuscript. Correspondence should be addressed to B.B. (
[email protected]) 1 bioRxiv preprint doi: https://doi.org/10.1101/314716; this version posted May 8, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Kinase and phosphatase overexpression drives tumorigenesis and drug resistance in many cancer types. Signaling networks reprogrammed by protein overexpression remain largely uncharacterized, hindering discovery of paths to therapeutic intervention. We previously developed a single cell proteomics approach based on mass cytometry that enables quantitative assessment of overexpression effects on the signaling network.